 Quidel Corporation NASDAQ: QDEL announced preliminary estimates for its Q3 revenues are expected to rise between 6 and 7 YY on COVID-19 assay sales. Related: Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales. 